Recruiting Lupus Nephritis Studies in Birmingham
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
This trial will evaluate efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 weeks (q12w) compared to placebo, in combination with SoC, in adult p...
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
The purpose of this study is to evaluate the efficacy and safety of IV antifrolumab in adult patients with Active Proliferative Lupus Nephritis...
About Lupus Nephritis Clinical Trials in Birmingham
Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.
There are currently 2 lupus nephritis clinical trials recruiting participants in Birmingham, ALABAMA. These studies are seeking a combined 780 participants. Research is being sponsored by Novartis Pharmaceuticals, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Nephritis Clinical Trials in Birmingham — FAQ
Are there lupus nephritis clinical trials in Birmingham?
Yes, there are 2 lupus nephritis clinical trials currently recruiting in Birmingham, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What lupus nephritis treatments are being tested?
The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.
Data updated March 2, 2026 from ClinicalTrials.gov